Metabolomics

Dataset Information

0

1H HR-MAS NMR Based Metabolic Profiling of Cells in Response to Treatment with a Hexacationic Ruthenium Metallaprism as Potential Anticancer Drug


ABSTRACT: 1H high resolution magic angle spinning (HR-MAS) NMR spectroscopy was applied in combination with multivariate statistical analyses to study the metabolic response of whole cells to the treatment with a hexacationic ruthenium metallaprism [1]6+ as potential anticancer drug. Human ovarian cancer cells (A2780), the corresponding cisplatin resistant cells (A2780cisR), and human embryonic kidney cells (HEK-293) were each incubated for 24 h and 72 h with [1]6+ and compared to untreated cells. Different responses were obtained depending on the cell type and incubation time. Most pronounced changes were found for lipids, choline containing compounds, glutamate and glutathione, nucleotide sugars, lactate, and some amino acids. Possible contributions of these metabolites to physiologic processes are discussed. The time-dependent metabolic response patterns suggest that A2780 cells on one hand and HEK-293 cells and A2780cisR cells on the other hand may follow different cell death pathways and exist in different temporal stages thereof.

INSTRUMENT(S): Bruker

PROVIDER: MTBLS156 | MetaboLights | 2015-01-16

REPOSITORIES: MetaboLights

Dataset's files

Source:
Action DRS
HRMAS_LP_001.dx Other
HRMAS_LP_002.dx Other
HRMAS_LP_003.dx Other
HRMAS_LP_004.dx Other
HRMAS_LP_005.dx Other
Items per page:
1 - 5 of 107
altmetric image

Publications

1H HR-MAS NMR Based Metabolic Profiling of Cells in Response to Treatment with a Hexacationic Ruthenium Metallaprism as Potential Anticancer Drug.

Vermathen Martina M   Paul Lydia E H LE   Diserens Gaëlle G   Vermathen Peter P   Furrer Julien J  

PloS one 20150529 5


(1)H high resolution magic angle spinning (HR-MAS) NMR spectroscopy was applied in combination with multivariate statistical analyses to study the metabolic response of whole cells to the treatment with a hexacationic ruthenium metallaprism [1](6+) as potential anticancer drug. Human ovarian cancer cells (A2780), the corresponding cisplatin resistant cells (A2780cisR), and human embryonic kidney cells (HEK-293) were each incubated for 24 h and 72 h with [1](6+) and compared to untreated cells. D  ...[more]

Similar Datasets

2014-09-11 | PXD001304 | Pride
2018-01-31 | MTBLS400 | MetaboLights
2012-04-10 | E-MTAB-1041 | biostudies-arrayexpress
2014-02-10 | GSE51356 | GEO
2014-02-10 | GSE51357 | GEO
2014-02-10 | GSE51355 | GEO
2019-07-04 | MTBLS1014 | MetaboLights
2022-01-24 | MTBLS1355 | MetaboLights
2016-06-28 | E-GEOD-83771 | biostudies-arrayexpress
2014-02-10 | E-GEOD-51355 | biostudies-arrayexpress